Endo Int'l (ENDP) Tops Q3 EPS by 24c; Reaffirms

Endo Int'l (NASDAQ: ENDP) reported Q3 EPS of $0.91, $0.24 better than the analyst estimate of $0.67. Revenue for the quarter came in at $787 million versus the consensus estimate of $784.56 million.

Company reaffirms full year 2017 revenues, adjusted diluted EPS and adjusted EBITDA financial guidance provided in August 2017

For earnings history and earnings-related data on Endo Int'l (ENDP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance